These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy. Masalha W; Heiland DH; Franco P; Delev D; Haaker JG; Schnell O; Scheiwe C; Grauvogel J J Neurooncol; 2018 Jan; 136(1):147-154. PubMed ID: 29081038 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis. Chun SW; Kim KM; Kim MS; Kang H; Dho YS; Seo Y; Kim JW; Kim YH; Park CK Radiat Oncol; 2021 Feb; 16(1):34. PubMed ID: 33596974 [TBL] [Abstract][Full Text] [Related]
7. Radiotherapy after surgery for benign cerebral meningioma. Soyuer S; Chang EL; Selek U; Shi W; Maor MH; DeMonte F Radiother Oncol; 2004 Apr; 71(1):85-90. PubMed ID: 15066300 [TBL] [Abstract][Full Text] [Related]
8. Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. Sun SQ; Cai C; Murphy RK; DeWees T; Dacey RG; Grubb RL; Rich KM; Zipfel GJ; Dowling JL; Leuthardt EC; Leonard JR; Evans J; Simpson JR; Robinson CG; Perrin RJ; Huang J; Chicoine MR; Kim AH Neurosurgery; 2014 Oct; 75(4):356-63; discussion 363. PubMed ID: 24932708 [TBL] [Abstract][Full Text] [Related]
9. Should adjuvant radiotherapy be used in atypical meningioma (WHO grade 2) following gross total resection? A systematic review and Meta-analysis. Wujanto C; Chan TY; Soon YY; Vellayappan B Acta Oncol; 2022 Sep; 61(9):1075-1083. PubMed ID: 36052871 [TBL] [Abstract][Full Text] [Related]
10. Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma. Wang C; Kaprealian TB; Suh JH; Kubicky CD; Ciporen JN; Chen Y; Jaboin JJ Neuro Oncol; 2017 Sep; 19(9):1263-1270. PubMed ID: 28371851 [TBL] [Abstract][Full Text] [Related]
11. Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control. Dohm A; McTyre ER; Chan MD; Fan C; Isom S; Bourland JD; Mott RT; Cramer CK; Tatter SB; Laxton AW J Clin Neurosci; 2017 Dec; 46():90-98. PubMed ID: 28917587 [TBL] [Abstract][Full Text] [Related]
12. Skull base atypical meningioma: long term surgical outcome and prognostic factors. Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Kaur G; Sayegh ET; Larson A; Bloch O; Madden M; Sun MZ; Barani IJ; James CD; Parsa AT Neuro Oncol; 2014 May; 16(5):628-36. PubMed ID: 24696499 [TBL] [Abstract][Full Text] [Related]
14. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma. Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the RoleĀ of Adjuvant Radiotherapy. Zhi M; Girvigian MR; Miller MJ; Chen JC; Schumacher AJ; Rahimian J; Lodin K World Neurosurg; 2019 Feb; 122():e1153-e1161. PubMed ID: 30447464 [TBL] [Abstract][Full Text] [Related]
16. Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis. Stessin AM; Schwartz A; Judanin G; Pannullo SC; Boockvar JA; Schwartz TH; Stieg PE; Wernicke AG J Neurosurg; 2012 Oct; 117(4):669-75. PubMed ID: 22900840 [TBL] [Abstract][Full Text] [Related]
17. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas. Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572 [TBL] [Abstract][Full Text] [Related]
18. Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy. Cain SA; Smoll NR; Van Heerden J; Tsui A; Drummond KJ J Clin Neurosci; 2015 Nov; 22(11):1742-8. PubMed ID: 26213286 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy for atypical meningiomas is associated with improved progression free survival. Unterberger A; Ng E; Pradhan A; Kondajji A; Kulinich D; Duong C; Yang I J Neurol Sci; 2021 Sep; 428():117590. PubMed ID: 34358821 [TBL] [Abstract][Full Text] [Related]
20. The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial. Jenkinson MD; Javadpour M; Haylock BJ; Young B; Gillard H; Vinten J; Bulbeck H; Das K; Farrell M; Looby S; Hickey H; Preusser M; Mallucci CL; Hughes D; Gamble C; Weber DC Trials; 2015 Nov; 16():519. PubMed ID: 26576533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]